投融资数据库
免费查数据
注册送3天会员
首页>投融资
Molecular Assemblies
收并购
Molecular Assemblies Inc is a developer of enzymatic DNA synthesis technology designed to power the next-generation DNA-based products. The company's technology is capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology, and other related fields, providing researchers with long, high-quality, sequence-specific DNA reliably and affordably.In March 2022, Molecular Assemblies Inc had raised $25.8 million Series B financing with participation from Casdin Capital, Agilent Technologies, iSelect Fund, Codexis, LYFE Capital, and Argonautic Ventures.In April 2021, Molecular Assemblies Inc had announced that it had closed an oversubscribed $24 million Series A financing with significant investment from Alexandria Venture Investments
基本信息
-
公司全称Molecular Assemblies Inc
-
类型酶DNA合成技术开发商
-
产业领域医疗器械
-
公司人数15人以下
-
地址9880 Campus Point Dr. Suite 110 SAN DIEGO CALIFORNIA 92121; US; Telephone: +18582573078;
-
联系电话(858) 201-3073
-
邮箱info@molecularassemblies.com
-
成立时间2013-01-01
投融资
-
2025-01-28
-
2022-03-15
-
2021-11-04
-
2021-04-15
-
2019-10-01
-
2016-12-12
- 加载更多
相关投融资企业
C轮
Akura Medical是Shifamed LLC的一家私人控股投资组合公司,正在开发下一代血栓切除设备,旨在通过一种易于使用的单程程序来简化血栓切除术,该程序可有效去除血栓。
收并购
Acera Surgical Inc develops and commercializes synthetic materials for regenerative medical applications
C轮
Okami Medical, Inc.是一家私有医疗器械公司,其使命是通过开发创新、多功能和直观的闭塞血管器械来满足患者和医生不断发展的需求。
目前Okami已开发出LOBO™血管闭塞系统,该系统的独特设计旨在为介入治疗的医生提供单设备,即一劳永逸的解决方案,从而无需多种栓塞设备即可阻塞多种动脉靶标。



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息